HSN-2C

KIF1A | 2011

What Is HSN-2C?

HSN-2C is a type of CMT caused by autosomal recessive mutations in the KIF1A gene. This gene provides instructions for making a motor protein that transports cargo along the length of nerve axons. Mutations in the KIF1A gene disrupt this function, leading to impaired nerve signal transmission.

HSN-2C is autosomal recessive, meaning that both copies of the gene must have a mutation to cause this subtype.

Clinical Features

The age of symptom onset in HSN-2C is variable, ranging from childhood to adulthood. The disease involves loss of sensation that begins in the hands and feet (glove-and-stocking distribution) and progresses over time towards the center of the body. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

HSN-2C symptoms may include:

  • Progressive loss of sensation in the feet and hands
  • Loss of pain and temperature sensation
  • Reduced or absent reflexes
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Distal weakness that develops as the disease progresses
  • Foot drop
  • Additional symptoms not listed here

Disease Course

HSN-2C shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
HSN-2C

Classification
HSN

Neuropathy Type
Axonal

Inheritance Pattern
autosomal recessive

Genetic Context

HGNC-Approved Gene Symbol
KIF1A

Gene Full Name
kinesin family member 1A

Chromosome
2q37.3

Zygosity of Responsible Variant
Homozygous or Compound Heterozygous

Variant Mechanism

Loss of Function (LoF)

Details

Mechanistic basis:
Complete loss

Confidence:
Medium

Prediction:
The literature predicts a biallelic loss-of-function mechanism for HSN-2C: the disease alleles are frameshifts confined to the alternatively spliced KIF1A exon 25b, homozygous in three unrelated families and compound heterozygous in a fourth, so the isoform that hauls dense-core and synaptic vesicle precursors down sensory axons is truncated while canonical kinesin-3 is spared. Heterozygous de novo motor-domain missense variants instead cause a dominant KIF1A-associated neurological disease.

Rationale:
Sparing the canonical isoform is what makes two truncating alleles survivable at all, since Kif1a-null mice do not live. The lesion is confined to a splice form the sensory neuron depends on, and carrier parents are neurologically intact, which places the phenotype at a threshold within that isoform rather than at any interference between mutant and normal motor.

ClinVar Pathogenic Variants

View KIF1A ClinVar Variants

HSN-2C OMIM Entry

HSN-2C OMIM

KIF1A OMIM Entry

KIF1A OMIM

More Info

HSN-2C Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

KIF1A, an Axonal Transporter of Synaptic Vesicles, is Mutated in Hereditary Sensory and Autonomic Neuropathy Type 2

Authors

Rivière, J. B., Ramalingam, S., Lavastre, V., Shekarabi, M., Holbert, S., Lafontaine, J., Srour, M., Merner, N., Rochefort, D., Hince, P., Gaudet, R., Mes-Masson, A. M., Baets, J., Houlden, H., Brais, B., Nicholson, G. A., Van Esch, H., Nafissi, S., De Jonghe, P., Reilly, M. M., … Rouleau, G. A.

Publication Date
August 4, 2011

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.